本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Aprea Therapeutics, Inc.

1.59
-0.0150-0.94%
盤後1.590.00000.00%16:04 EDT
成交量:5.63萬
成交額:8.90萬
市值:923.30萬
市盈率:-0.69
高:1.62
開:1.62
低:1.54
收:1.60
52周最高:5.01
52周最低:1.41
股本:582.53萬
流通股本:431.55萬
量比:1.35
換手率:1.30%
股息:- -
股息率:- -
每股收益(TTM):-2.3101
每股收益(LYR):-2.3519
淨資產收益率:-67.54%
總資產收益率:-39.12%
市淨率:0.69
市盈率(LYR):-0.67

資料載入中...

2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/12

重要事件披露

8-K - Current report
2020/12/28

重要事件披露

8-K - Current report
2020/11/25

SEC問詢函

CORRESP [Cover] - Correspondence
2020/11/19

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/11/12

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/11/06

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/05

重要事件披露

8-K - Current report
2020/10/07

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/09/29

重要事件披露

8-K - Current report
2020/09/18

重要事件披露

8-K - Current report
2020/08/11

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/11

重要事件披露

8-K - Current report
2020/06/30

重要事件披露

8-K - Current report
2020/06/16

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/05/22

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership